Results 331 to 340 of about 63,117 (342)

Nutrition and physical activity guidelines for cancer survivors

Ca-A Cancer Journal for Clinicians, 2012
Cheryl L Rock, Wendy Demark-Wahnefried, Kerry S Courneya   +2 more
exaly  

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Emerging role of advanced glycation-end products (AGEs) in the pathobiology of eye diseases

Progress in retinal and eye research, 2014
S. A. Kandarakis, C. Piperi, F. Topouzis, A. Papavassiliou   +3 more
semanticscholar   +1 more source

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Gastroenteropancreatic Neuroendocrine Tumors

Ca-A Cancer Journal for Clinicians, 2018
Mauro Cives
exaly  

Hodgkin lymphoma: A review and update on recent progress

Ca-A Cancer Journal for Clinicians, 2018
Satish P Shanbhag, Richard F Ambinder
exaly  

The combination of high glucose and advanced glycation end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced increase in the receptor for AGEs.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2007
N. Ogawa, Toru Yamaguchi, S. Yano, M. Yamauchi, M. Yamamoto, T. Sugimoto   +5 more
semanticscholar   +1 more source

Food-derived advanced glycation end products (AGEs): a novel therapeutic target for various disorders.

Current pharmaceutical design, 2007
S. Yamagishi, S. Ueda, S. Okuda
semanticscholar   +1 more source

Improving patient and caregiver outcomes in oncology: Team‐based, timely, and targeted palliative care

Ca-A Cancer Journal for Clinicians, 2018
David Hui, Camilla Zimmermann, Eduardo Bruera   +2 more
exaly  

Immunotherapy of cancer in 2012

Ca-A Cancer Journal for Clinicians, 2012
Lisa H Butterfield, Ahmad A Tarhini
exaly